CRBU Caribou Biosciences, Inc.
$0.46▼ -6.40%
Healthcare
Other
Pre-market
$0.51▲ +10.31%
Oct 28, 4:00 AM ET
Volume 2.36M
Avg Volume (10D) 2.82M
Key Metrics & Fundamentals
Market Cap
$49.39M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.44 - 3.54
% vs 50 MA
-59.65%
% vs 200 MA
-72.03%
RSI-14
22.2
MACD Histogram
+0.0200
Beta (1Y vs SPY)
2.09
Free Cash Flow
-$22.79M
Gross Rev
$1.50M
Gross Profit
$1.50M
EBITDA
-$24.71M
COGS
–
Operating Exp
$26.84M
Operating Income
-$25.34M
EBIT
-$25.34M
Pretax Income
-$24.28M
Net Income
-$24.28M
EPS (Diluted)
-0.24
Price & Volume History
Loading chart…
Recent News
Caribou Biosciences (CRBU) Stock Fair Value Falls After Clinical Programs Are Halted
Simply Wall St. · Oct 28, 2026 2:16 AM ET
Caribou Biosciences Shares Fall After HC Wainwright Downgrade
MT Newswires · Oct 8, 2026 3:40 PM ET
In the hunt for reverse merger targets, Caribou could be prized game
BioPharma Dive · Oct 8, 2026 11:23 AM ET
HC Wainwright Downgrades Caribou Biosciences to Neutral From Buy
MT Newswires · Oct 8, 2026 6:20 AM ET
Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
BioPharma Dive · Oct 7, 2026 11:37 AM ET
CAR-T specialist Caribou culls pipeline and seeks exit deal
Pharmaceutical Technology · Oct 7, 2026 11:16 AM ET
Caribou Shares Fall After Plans to Evaluate Strategic Alternatives, Discontinue CAR-T Programs
MT Newswires · Oct 7, 2026 10:16 AM ET
Leerink Partners Downgrades Caribou Biosciences to Market Perform From Outperform, Price Target is $1
MT Newswires · Oct 7, 2026 7:53 AM ET
Top Premarket Decliners
MT Newswires · Oct 7, 2026 7:38 AM ET
CRBU Stock Crashes 35% Premarket — RBC Slashes Target By 90% After Caribou Scraps CAR-T Programs
Stocktwits · Oct 7, 2026 6:49 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CRBU's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.